A planning application for a new, state-of-the-art global continuous glucose monitoring manufacturing facility at Athenry has been submitted to Galway County Council.
The new facility represents a €300 million investment over five years and the potential to bring c. 1,000 high-skilled jobs to the region.
Subject to planning, the new facility will have the capacity to produce millions of Dexcom Continuous Glucose Monitoring (CGM ) sensors each year, helping to improve the lives of people with diabetes around the world.
The proposed factory in Athenry is expected to deliver substantial economic benefits to the local community and the broader West and Midlands regions.
Once operational, the facility will directly employ circa 1,000 people, onboarded over a five-year period across various functions, including manufacturing, research and development, quality control, and administration.
Some 500 workers are expected to be employed during the 24-month construction phase.
The company held two open public information evenings in Athenry on the August 23 and 2423rd where they displayed images and details of the proposed facility and project team members were on hand to answer questions.
Headquartered in California, Dexcom is a leading developer, manufacturer, and distributer of continuous glucose monitoring (CGM ) systems for diabetes management. The new facility will be Dexcom’s first production plant in Europe. Building on the success of its latest CGM device, Dexcom G7, the company is pursuing an ambitious growth strategy which involves significant investment in growing its share of the European market.
Dexcom is a pioneer in CGM. Since 1999, it has developed innovative technology that has transformed how people manage diabetes. It has more than 8,000 employees across the globe dedicated to creating life changing CGM solutions.